Amgen bought Ch...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
ChemoCentryx
Amgen bought ChemoCentryx
10/20/22 at 16:16
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.
ChemoCentryx
Review
Source:
investors.amgen.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Yandex commented on the company's restructuring
5/25/23
YNDX
Board of Directors of Moscow confectionery factory Krasny Oktyabr recommended that dividends be paid for 2022
5/25/23
KROT
Shareholders of LUKOIL approved dividends for 2022
5/25/23
LKOH
Ozon opened its sixth Fulfillment Center in the Moscow region
5/25/23
OZON
Yandex shareholders may be offered several options for dividing the business
5/25/23
YNDX
VK releases beta version of VK Videos app
5/25/23
VKCO
Developer Samolet bought the real estate agency Zoltor
5/25/23
SMLT
The NetEase announced a quarterly dividend
5/25/23
NTES
The NVIDIA announced a quarterly dividend
5/25/23
NVDA
NetEase reported for 3 months of 2023
5/25/23
NTES
«
Previous
604
605
606
607
608
609
610
611
612
613
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)